KIMBERLY MISLICK, M.D.
Medical Practice in Los Angeles, CA
License number
California A79154
Category
Medical Practice
Type
Anatomic Pathology & Clinical Pathology
Address
Address
10833 Leconte Ave., Los Angeles, CA 90095
Phone
(310) 794-1355
(310) 301-8751 (Fax)
(310) 301-8708
(310) 301-8751 (Fax)
(310) 301-8708
Personal information
See more information about KIMBERLY MISLICK at radaris.comName
Address
Phone
3848 Lilac Canyon Ln, Altadena, CA 91001
Organization information
See more information about KIMBERLY MISLICK at bizstanding.comKimberly Mislick MD
10833 Le Conte Ave, Los Angeles, CA 90095
Industry:
Dermatologist
Phone:
(310) 794-1355 (Phone)
Kimberly Ann Mislick
Professional information
See more information about KIMBERLY MISLICK at trustoria.com
Kimberly Mislick, Los Angeles CA
Kimberly Mislick, Los Angeles CA
Specialties:
Pathologist
Address:
10833 Le Conte Ave, Los Angeles, CA 90095
Education:
Doctor of Medicine
Board certifications:
American Board of Pathology Certification in Clinical Pathology (Pathology), American Board of Pathology Sub-certificate in Dermatopathology (Pathology)
Kimberly Ann Mislick, Los Angeles CA
Kimberly Ann Mislick, Los Angeles CA
Specialties:
Pathology, Anatomic Pathology & Clinical Pathology, Dermatopathology, Dermatopathology
Work:
UCLA Medical Center
10833 Le Conte Ave, Los Angeles, CA 90095
10833 Le Conte Ave, Los Angeles, CA 90095
Education:
University of California at Los Angeles (2000)
Method For Increasing Or Decreasing Transfection Efficiency
Method For Increasing Or Decreasing Transfection Efficiency
US Patent:
5783566, Jul 21, 1998
Filed:
May 10, 1996
Appl. No.:
8/644095
Inventors:
Kimberly Ann Mislick - Los Angeles CA
Assignee:
California Institute of Technology - Pasadena CA
International Classification:
A61K 3800, A61K 4800, C12N 500, C12N 1500
US Classification:
514 44
Abstract:
Methods for controlling transfection efficiency mediated by complexes of cationic species and genetic material by adjusting the amount of membrane-associated proteoglycans and optionally adjusting the plasma concentration of glycosaminoglycans. Transfection efficiency is controlled by the amount of membrane-associated proteoglycans in the cell to be transfected and also by the plasma concentration of glycosaminoglycans. By increasing the amount of membrane-associated proteoglycans in the cell, and optionally decreasing the plasma concentration of glycosaminoglycans, the transfection efficiency can be increased. By decreasing the amount of membrane-associated proteoglycans in the cell, and optionally decreasing the plasma concentration of glycosaminoglycans, the transfection efficiency can be decreased. Transfection efficiency can be controlled, whether performed in vivo, ex vivo, or in vitro.